Publications in collaboration with researchers from University of Colorado Cancer Center (2)

2019

  1. Phase I study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) administered with PD-L1 inhibitor (atezolizumab) in advanced solid tumors

    Clinical Cancer Research, Vol. 25, Núm. 11, pp. 3220-3228

2015

  1. Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in locally advanced or metastatic epithelial tumors

    Clinical Cancer Research, Vol. 21, Núm. 11, pp. 2462-2470